Results 151 to 160 of about 16,895 (259)

Circulating neprilysin hypothesis

Circulating Neprilysin (sNEP) has emerged as a potential prognostic biomarker in heart failure (HF). In PARAGON-HF benefit of sacubitril/valsartan was only observed in patients with left ventricular ejection fraction (LVEF) ≤57%. We aimed to assess the prognostic value of sNEP in outpatients with HF and LVEF >57%, in comparison with patients with LVEF ≤
Lupón, Josep||, Santiago Vacas, Evelyn||, Cediel, Germán||, Codina, Pau||, Domingo, Mar||, Revuelta-López, Elena||, Zamora, Elisabet||, Spitaleri, Giosafat||, Santesmases, Javier||, Núñez, Julio||, Bayés-Genís, Antoni||   +10 more
openaire   +1 more source

Sacubitril/valsartan fails to prevent doxorubicin-induced cognitive impairment and hippocampal oxidative, inflammatory, and apoptotic alterations in rats. [PDF]

Front Pharmacol
Alresheedi MM, Aldubayan MA.
europepmc   +1 more source

PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction [PDF]

, 2019
Kieran F. Docherty, John J.V. McMurray
openalex   +1 more source

Angiotensin receptor-neprilysin inhibitors improve the outcome of lung cancer patients with hypertension undergoing immune checkpoint inhibitors treatment. [PDF]

BMC Cardiovasc Disord
Shang C, Wang H, Chen J, Cao S, Sun Y, Sheng Z, Chu T, Zhao L.   +7 more
europepmc   +1 more source

Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients [PDF]

, 2018
Niel Shah, Muhammad Dogar, Parin Shah, Sameera Ishtiaq, Shawn Mathew, Pratik Shah, Alia Ishtiaq, Timothy J. Vittorio   +7 more
openalex   +1 more source

Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure. [PDF]

Commun Med (Lond)
Hsu WH, Shiau BW, Wu JY, Chuang MH, Tsai YW, Huang PY, Hu KC, Hsu W, Liu TH, Liao KM, Lai CC.   +10 more
europepmc   +1 more source

The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors

, 2021
Yu. V. Mareev, Mareev VIu
openalex   +2 more sources

Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNis) in High-Output Heart Failure in a Young Hemodialysis Patient: Synergistic or Cumulative Effect? [PDF]

Cureus
Silva SR, Soares E, Natário A, Gama A, Bernardo T.   +4 more
europepmc   +1 more source

Investigating the binding potential of the Melissa officinalis oil against Alzheimer's targets by molecular docking and in vitro evaluations. [PDF]

Sci Rep
Kolouei A, Barati M, Abbas-Mohammadi M.
europepmc   +1 more source

Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models [PDF]

, 2014
Mathew Blurton‐Jones, Brian Spencer, Sara Michael, Nicholas A. Castello, Andranik A. Agazaryan, Joy Davis, Frank Müller, Jeanne F. Loring, Eliezer Masliah, Frank M. LaFerla   +9 more
openalex   +1 more source